Pregnancy
Few data are available on atazanavir (Reyataz) use in pregnancy. One small observational study involving nine women taking atazanavir has shown that it is well tolerated during pregnancy. This included six women taking ritonavir (Norvir)-boosted atazanavir. All of the women had viral loads below 100 copies/ml by delivery, and there were no liver, kidney or pancreas side-effects. Three of the eight babies born had mild bilirubin elevations, and all eight were HIV-negative after birth[1].
latest aidsmap news
- Microbicide and PrEP potential for anal sex explored further in monkey studies
- ‘Shocking’ rates of adverse events seen with traditional and medical circumcision in Kenya
- Brazil rejects tenofovir patent
- Fibrosis linked to rapid loss of gut CD4 cells after HIV infection
- Poor results using non-medical HIV counsellors to screen for treatment eligibility in Malawi
- Raltegravir may cause temporary worsening of pre-existing depression
- Etravirine (<i>Intelence</i>) approved in Europe for treatment-experienced patients
- Belief in conspiracy theories means less HIV testing in South Africa
- Case report - viral load undetectable in blood, but detectable in semen
- Blood viral load predicts HIV transmission better than semen viral load in small study among MSM
